Previous close | 141.00 |
Open | 140.10 |
Bid | 140.60 x 0 |
Ask | 141.25 x 0 |
Day's range | 140.10 - 140.10 |
52-week range | 104.90 - 148.05 |
Volume | |
Avg. volume | 5 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, April 25, 2024--Wolters Kluwer, a global leader in information, software, and services for professionals, announces that it has won two Stevie® Awards at the 2024 American Business Awards®. Wolters Kluwer TeamMate+ ESG has been recognized as a Gold Stevie winner in the compliance solution category and Enablon ESG Excellence received a Silver Stevie Award in the emerging technology category.
NEW YORK, April 25, 2024--Wolter’s Kluwer’s MediRegs has been named a winner in the Healthcare category of the 2024 BIG Innovation Awards. The solution, offered by the company’s Legal & Regulatory division, recently launched an Analytical APIs service leveraging automated analytics. Healthcare revenue cycle, reimbursement, and audit professionals can now use MediRegs to bolster efficiency and cash collections during the audit and appeals process.
Share Buyback Transaction Details April 18 – April 24, 2024 April 25, 2024 - Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 159,569 of its own ordinary shares in the period from April 18, 2024, up to and including April 24, 2024, for 22.6 million and at an average share price of €141.62. These repurchases are part of the share buyback program announced on February 21, 2024, under which